Regulatory Reporting Timelines

Regulatory Reporting Timelines is a standardized procedural framework within pharmacovigilance compliance that specifies the mandated timeframes for submitting safety reports and adverse event data to regulatory authorities, thereby distinguishing it from general reporting practices by its legally enforceable temporal requirements.

8

Publications

859

Citations

33

Authors

20

Institutions

Publications per year

2017–2026

4

Authors

33

  1. KD
    Karolina Danysz

    Bristol-Myers Squibb (Switzerland), Switzerland

    1 publications · 22 citations

    1

    h-index

  2. KC
    Karen Chiswell

    Clinical Research Institute, United States

    1 publications · 382 citations

    1

    h-index

  3. NT
    Niki Tetarenko

    Bristol-Myers Squibb (Switzerland), Switzerland

    1 publications · 22 citations

    1

    h-index

  4. JG
    Joey Gouws

    University of the Witwatersrand, South Africa

    1 publications · 39 citations

    1

    h-index

  5. RM
    Ruta Mockute

    Bristol-Myers Squibb (Switzerland), Switzerland

    1 publications · 22 citations

    1

    h-index

1–5 of 33

Venues

  1. Therapeutic Innovation & Regulatory Science

    TIRS · 1 publications · 39 citations

    1

    h-index

  2. Trials

    1 publications · 30 citations

    1

    h-index

  3. PLoS Medicine

    1 publications · 289 citations

    1

    h-index

  4. Cancer Discovery

    1 publications · 31 citations

    1

    h-index

  5. UCL Discovery (University College London)

    Repository · 1 publications · 27 citations

    1

    h-index

1–5